Form 4: Elanco EVP Modi Buys 4,500 Shares

Elanco Animal Health Inc.'s Executive Vice President, Rajeev A. Modi, purchased 4,500 shares of common stock at $21.33 per share, increasing his direct beneficial ownership to 123,082 shares.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), acquired 4,500 shares of common stock.
• The transaction occurred on December 11, 2025, at a price of $21.33 per share.
• Following this purchase, Modi directly beneficially owns a total of 123,082 shares of Elanco common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• The total beneficial ownership includes 1,579 shares acquired on January 31, 2025, and 205 shares acquired on April 30, 2025, under the company's Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The purchase of company stock by a high-ranking executive, especially under a pre-arranged plan, typically signals management's confidence in the company's current valuation and future growth prospects. This is generally viewed as a positive indicator for investors.

Positives

• An executive purchasing company stock signals confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy rather than a reaction to immediate news.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, but an insider purchase can be interpreted as a positive signal regarding management's belief in the company's future performance.

Management Comments

• Executive Vice President U.S. Pet Health and Global Digital Transformation (title of Rajeev A. Modi).

Industry Context

Insider purchases, particularly by high-ranking executives, are generally viewed positively across industries as they suggest management's confidence in the company's valuation and future prospects. In the animal health sector, such a purchase by an EVP overseeing key areas like U.S. Pet Health and Global Digital Transformation could imply optimism about strategic initiatives or market positioning.

Comparison to Industry Standards

• While specific comparable companies or projects are not detailed in this Form 4, insider buying is a common indicator of management confidence.
• A purchase of 4,500 shares by an EVP, especially under a 10b5-1 plan, aligns with typical insider investment patterns seen in established companies across various sectors, including pharmaceuticals and animal health, where executives often hold significant equity stakes.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive signal, potentially increasing confidence in the stock.
• Employees could see this as a sign of stability and confidence from leadership.

Key Dates

Recommendation

The purchase of 4,500 shares by a key executive, Rajeev A. Modi, at a price of $21.33, signals strong insider confidence in Elanco Animal Health Inc.'s future performance and valuation. This transaction, executed under a Rule 10b5-1 plan, suggests a deliberate investment decision rather than a reactive one. Insider buying is generally considered a bullish indicator, suggesting that those closest to the company believe the stock is undervalued or poised for growth. For a seasoned investor, this action by an EVP overseeing critical business segments like U.S. Pet Health and Global Digital Transformation provides a positive signal to consider a 'buy' position, assuming it aligns with their broader investment thesis for the animal health sector.

Keywords

Elanco Animal Health, ELAN, Insider Trading, Stock Purchase, Rajeev A. Modi, Executive Vice President, Form 4, SEC Filing, Common Stock, Rule 10b5-1